Navigation Links
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Date:12/14/2007

rican, California, and San Diego bar associations.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis Pharmaceuticals and the Company's business. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward- looking stateme
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, E... Market dynamics and the changing healthcare and r...ker.com/p0165658/Emerging-Clinical-Trial-Locations...-healthcare-and-regulatory-environment.html ,,...
(Date:12/1/2009)..., , CAMBRIDGE, Mass., Dec. 1 /PRNews... biology industry and to promote its potential, a ...ormation of the Synthetic Biology Industry Associa...k. The goal of the association is to provide a for...cuss the new industry, address its opportunities a...
(Date:12/1/2009)..., , SHANGHAI, Dec. 1 /PRNewswire-Asia/...ry of ShangPharma, a leading China-based Contract ... a winner of the 2009 Deloitte,Technology Fast 50 ...ing high,tech companies in China. The award is a t...evenue growth from 2006 to 2008. , The re...
(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswir...is proud to announce that it was recently awarded ...wards event on Nov. 13 in New York City. The CLIO ...nd innovation in the healthcare advertising indust...the world,s most recognized awards competitions fo...
Breaking Biology Technology:Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2
...to courtesy of Silicon Graphics Inc. Chippewa Va...the world,s fastest supercomputer in about 129 day...sin, plant that pulled the project together. SGI a... for NASA last week. , ,The supercomputer, named...t year, runs on SGIs Altix 3700 systems and 10,2...
...quently wish for more hours in the day so I can ge... a year, that wish comes true. We "fall back" into...e do with the extra hour? , ,I decided to clean my...re time. In the process, I found several odds and ...e they are, in no particular order, except for the...
...dison, Wis. NimbleGen , a Madison biotech firm ...ins of the 2003 Severe Acute Respiratory Syndrome ...ture capital. , ,The company has raised a total of...t Palay, chairman of NimbleGens board, expects the...ies in micro-array technology. He said there is a ...
Other Biology Technology:SGIs Wisconsin branch builds fastest supercomputer yet in four months 2Music, mail, databases and printing from a technologists desk 2Music, mail, databases and printing from a technologists desk 3Wisconsin company with SARS diagnostic role lands $13 million investment 2
(Date:12/2/2009)...status did not prompt people participating in a lo...creening program to pick up their cigarettes again...r Epidemiology, Biomarkers & Prevention , a journa... The December issue contains a special focus on to... concern in the lung screening community that reas...
(Date:12/2/2009)...ter researchers have figured out how stem cells in...ble to resist radiation therapy. And using a drug ...ancer stem cells, they were able to kill many more...iment. , The work builds off earlier research w...cts of radiation much better than other cancer cel...
(Date:12/2/2009)...tification of substances involved in the Jekyll-an... bacteria into killers that cause "coral bleaching...nce & Technology , a semi-monthly journal. , Dan...y has destroyed up to 30 percent of the world,s co...o slow or stop the damage. One known culprit is an...
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Social support buffers adolescent depression after terrorist attacks 3A Ben Gurion University 52133 1Social support buffers adolescent depression after terrorist attacks 3A Ben Gurion University 52133 2Iowa State University researchers develop process for surgical genetic changes 9291 1Iowa State University researchers develop process for surgical genetic changes 9291 2Iowa State University researchers develop process for surgical genetic changes 9291 3Reveal the enemy 9290 1
...tists will embark this week from Punta Arenas, Chi...amid the high winds and waves of the Southern Ocea...nts to explain how huge fluxes of climate-affectin...versa. , The cruise, which departs Feb. 28, sh...nhouse gas carbon dioxide moves between the ocean ...
...release is available in Spanish . , A research...o produce the most useful material to date to elim...ne, organic solvents widely used in the hydrocarbo.... The world-wide problem of the exposure to aromat...n benzene, which is considered to be harmful to he...
...CRUZ, CA--Seabird colonies on islands are highly v...d-nesting birds to be easy prey. But the ecologica...bird nesting colonies, according to a new study by...a Cruz. , The study, which will be published the...the National Academy of Sciences, has already help...
Other Biology News:Voyage to Southern Ocean aims to study air-sea fluxes of greenhouse gases 2Creation of a new material capable of eliminating pollutants by the hydrocarbon industry 2Rats on islands disrupt ecosystems from land to sea, researchers find 2Rats on islands disrupt ecosystems from land to sea, researchers find 3
Lambda Control Kit from ABgene
...olymerase. It is a 5'-exo-minus N-terminally trunc...rom a gene construct in E. coli, translation initi...main of the DNA polymerase-encoding gene. The enzy...le DNA polymerase activity in comparison with Taq ...
Rabbit Anti-Human XM_941015 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
96 Well Base Plate from ABgene
Biology Products: